Could erectile dysfunction be a side effect of CGRP inhibition? A case report

BACKGROUND: Recently, antimigraine drugs targeting the calcitonin gene-related peptide pathway have been approved for clinical use as preventive migraine medication. CASE REPORT: We present a case of a 54-year-old male migraine patient, who reported erectile dysfunction as a possible side effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hassany, Linda, de Vries, Tessa, Carpay, Johannes A, MaassenVanDenBrink, Antoinette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988460/
https://www.ncbi.nlm.nih.gov/pubmed/34404250
http://dx.doi.org/10.1177/03331024211037304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988460/
https://www.ncbi.nlm.nih.gov/pubmed/34404250
http://dx.doi.org/10.1177/03331024211037304

Ejemplares similares